Antibody-based therapies for COVID-19: Can Europe move faster?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32369479.
- Also identified by DOI 10.1371/journal.pmed.1003127 and PMC identifier 7200003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus.
Medical subject headings
- Antibodies, Viral
- Betacoronavirus
- Coronavirus Infections
- Pneumonia, Viral